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httcense.Abstract Background/aim: Study the role of BAL cellularity in assessment of the degree of sever-
ity of IPF.
Methods: Forty IPF patients underwent, history taking, clinical examination, HRCT chest,
ABGs, 6MWT, spirometry, echocardiography, FOB and BAL.
Results: Neutrophils were present in 28 patients, mean value 57.25 and SD ± 31.27. The second
predominant cell wasAlveolarMacrophages withmean value 24.25 and SD± 27.828.HRCTpattern
and BAL cellularity, showed the most predominant cell neutrophils in the ground glass and Honey
combing on HRCT. There was no statistical signiﬁcance between the sex and the BAL cellularity,
the most predominant cell was neutrophils in both sexes. Corticosteroids did not have an effect on
BAL cellularity and the predominant cell was neutrophils in IPF patients using steroids and those
not. BAL cellularity in relation to treatment by azathioprine and/or acetlycysteine showed no statis-
tical signiﬁcance between patients using those drugs and those not, themost predominant cell was neu-
trophils in both groups.Correlation between BAL cellularity and age, showed no statistical
signiﬁcance but there was a negative correlation between age to neutrophils and lymphocytes. There
was a negative correlation between neutrophils and PaCO2, PaO2, SO2, FVC%, FEV1 and 6MWT
with no statistical signiﬁcance but with signiﬁcance to FEF25–75%.Macrophages showed a positive
correlation with age, PaO2, 6MWT, FVC%, FEV1% with no statistical signiﬁcance but with signiﬁ-
cance to SO2 and FEF25–75% and a negative correlation with PaCO2 and PASP.
Conclusion: There was a positive correlation between neutrophils and severity of the disease and a
negative correlation betweenMacrophages and severity of the disease.Most commonly useddrugs did
not show any effect on BAL cellularity.
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IPF is deﬁned as a speciﬁc form of chronic, progressive ﬁbro-
sing interstitial pneumonia of unknown cause, occurring pri-
marily in older adults, limited to the lungs, and associated
with the histopathologic and/or radiologic pattern of UIP [6].
IPF is a fatal lung disease; the natural history is variable
and unpredictable. Most patients with IPF demonstrate a
gradual worsening of the lung function over years; a minority
of patients remains stable or declines rapidly. Some patients
may experience episodes of acute respiratory worsening despite
previous stability [6].
Disease progression is manifested by increasing respiratory
symptoms, worsening pulmonary function test results, pro-
gressive ﬁbrosis on HRCT, acute respiratory decline, or death.
Cellular analyses of BAL can be useful in the diagnosis of cer-
tain forms of ILD and in the evaluation of patients with sus-
pected IPF [6].
Materials and methods
This study was conducted on 40 patients form Chest Depart-
ment – Kasr El-Aini Hospital.
(A) Inclusion criteria
All patients were fulﬁlling major and minor criteria of ATS/
ERS consensus classiﬁcation of the idiopathic interstitial pneu-
monias [9].
(B) Exclusion criteria
1. Systemic disease such as connective tissue or hepatic disor-
ders, Vasculitis, and Sarcoidosis.
2. Malignancy or drug induced.
All cases were subjected to the following:
1. Full history taking.
2. Full clinical examination.
3. High resolution CT chest.
4. Arterial blood gases.
5. Pulmonary function tests.
6. Echocardiography.
7. Six minute walk test.
8. FOB and lavage for cellularity.
Flexible bronchoscopy and bronchoalveolar lavage cellular
analysis.
 The procedure was performed using a ﬂexible ﬁberoptic
bronchoscope PENTAX (FB-18 RX).
 Premedication: includes an intramuscular injection of atro-
pine (0.6 mg) 30 min before bronchoscopy.
 Monitoring: with pulse oximeter.
 Technique:
o Oxygen is supplied to ensure that SpO2 is above 90%.
o Local anesthesia includes: topical xylocaine 1% to
anesthetize vocal cords and the airways.o Bronchoscope was introduced intranasally and a thor-
ough inspection of all segments was done where it was
wedged into one of the segments of the right lower
lobe.
o BAL was performed using 100 mL of sterile saline
injected through the bronchoscope working channel
and then extracted using the mechanical suction with
a negative pressure of about 60–80 mmHg to avoid air-
way collapse.Analysis of the bronchoalveolar lavage ﬂuid for differential cell
count
After the volume of recovered BAL ﬂuid had been assessed
macroscopically for its volume, color and aspect, the ﬂuid
was ﬁltered through a layer of sterile gauze, centrifuged for
15–20 min at 500g, then re-suspended in sterile saline. Total
cell counts were assessed in a Neubauer chamber and viability
was determined by the trypan blue exclusion test and proved to
be more than 75%. Direct smears and cytospin smears were
prepared. The cytospin preparation was centrifuged at 200g
for 6 min in a cytocentrifuge (Shandon Cytospin 3, Thermo
Electron Corporation). The cytospin smear was air-dried. Both
the direct and cytospin smears were stained with modiﬁed
Wright stain (May-Gru¨nwald-Giemsa). A 150- to 200-cell
nucleated differential count from 5 or more ﬁelds of the
stained cytospin preparation was made by using the 100· oil
objective [10].
Statistical analysis
Quantitative data were presented as minimum, maximum,
means and standard deviation (SD) values. One way ANOVA
(Analysis of Variance) was used to compare between means
among mild, moderate and severe asthma patients. Duncan’s
test for pair-wise comparisons was used to determine signiﬁ-
cant differences between means when ANOVA test is
signiﬁcant.
Qualitative data were presented as frequencies and percent-
ages. The Chi-square (v2) test was used for studying the com-
parisons and associations between different qualitative
variables.
The signiﬁcance level was set at P 6 0.05. Statistical analy-
sis was performed with SPSS 16.0 (Statistical Package for
Scientiﬁc Studies) for Windows (SPSS, Inc., Chicago, IL,
USA).
Results
This study included 32 female IPF patients (80%) and 8 male
IPF patients (20%) with a mean age of 47.7 years.
HRCT chest showed that, Honey combing was the predom-
inant pattern in 65% of patients, 20% of patients had ground
glass appearance and only 15% of patients had predominantly
reticulation on HRCT.
Arterial blood gases showed mean PaO2 was 62.45 with
SD ± 18.62 while the mean value of PaCO2 was 40 with
SD ± 9.66. Although the mean PaO2 was 62.45, 80% of the
IPF study patients had Type I respiratory failure.
Table 1 Patients on medications during study.
Medications No. %
Steroids No 12 30
Yes 28 70
Azathioprine No 20 50
Yes 20 50
ACC No 18 45
Yes 22 55
50% of patients were on steroids, azathioprine and acetyl cysteine.
5% of patients were on steroids and acetyl cysteine.
15% of patients were on steroid only.
30% of patients were without treatment.
Table 2 BAL cellularity in the study.
Mean ± SD (No. = 40)
Neutrophils (No. = 38) 57.25 ± 31.266
Lymphocytes (No. = 14) 4.75 ± 8.188
Macrophages (No. = 28) 24.25 ± 27.828
Epithelial cells (No. = 24) 13.75 ± 22.353
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mean FVC% was 45.35 with SD ± 17.43 while the mean
FEV1% was 42.4 with SD ± 21.95 consistent with the restric-
tive pattern.
The mean value of 6MWT in the current study was
160.57 m with SD ± 50.74.
Sixty percent of the patients did not have pulmonary hyper-
tension while 40% had pulmonary hypertension with a mean
value of 19.55 mmHg and SD± 26.01 (Table 1).
Correlations.
1. Age There is a negative correlation between
age and BAL neutrophils and
lymphocytes
2. PCO2 There is a negative correlation to
neutrophils and macrophages
3. PO2 There is a negative correlation to
neutrophils and lymphocytes
4. SO2 There is a negative correlation to
neutrophils and lymphocytes
There is a positive correlation to
macrophages with P-value: 0.04 denoting
statistical signiﬁcance
5. 6MWT There is a negative correlation to
neutrophils
6. FVC% There is a negative correlation to
neutrophils and epithelial cells
7. FEV1 There is a negative correlation to
neutrophils
8. FEF25–75% There is a negative correlation to
neutrophils with P-value: 0.003 denoting
statistical signiﬁcance
There is a positive correlation to
macrophages with P-value: 0.02 denoting
statistical signiﬁcance
9. PASP There is a positive correlation to
lymphocytes with P-value: 0.035 denoting
statistical signiﬁcance
There is a negative correlation to
macrophagesFigure 1 BAL cellularity in the study.
Discussion
Our study indicated a higher incidence of IPF among females
compared to males. This is contradicting the ATS/ERS Inter-
national Multidisciplinary Consensus Classiﬁcation of the IPF
stating that more males have been reported to have IPF than
females, our mean age was consistent with ATS/ERS
statement.
In this study the differential cellular analysis in the bron-
choalveolar lavage showed that the predominant cell is neutro-
phils followed by alveolar macrophages (Table 2; Fig. 1).
Obayashi et al. [5] stated that although the neutrophil count
in BAL could not represent the distribution of neutrophil in
the lung, high levels of neutrophil elastase were demonstrated
in lung parenchyma and also in both BAL and sera. Therefore,
neutrophils might indeed play an important role in the patho-
genesis of IPF.
Schwartz et al. [7], showed that patients with IPF had high-
er concentrations of BAL alveolar macrophages than non-
smoking volunteers.Alternatively activated macrophages (M2 phenotype) are
crucial in the pathogenesis of IPF enhancing ﬁbrogenesis of
ﬁbroblasts by providing proﬁbrogenic factors, favoring cell
growth, collagen formation and tissue repair [2].
By looking at the relation between the HRCT pattern and
the BAL cellularity, it was found that the most predominant
cell was neutrophils in the ground glass and Honey combing
HRCT pattern (Table 3).
Agusti et al. [1] stated that BAL neutrophilia correlated
with the total extent of pulmonary abnormalities on the
HRCT scan and with the extent of the ground glass pattern
in the lavaged lobe. These ﬁndings are supported by the fact
that the inﬂammatory process in IPF is characterized by a sus-
tained accumulation of neutrophils in the alveolar spaces.
Also Wells et al. [12] stated that BAL neutrophil levels in-
crease with increasingly extensive disease on CT.
Regarding the statistical comparison between males and
females according to BAL cellularity, there is no statistical
Table 4 Statistical comparison between males and females to BAL cellularity.
Sex Neutrophils Lymphocytes Macrophages Epithelial cells
Female No. 32 32 32 32
Mean ± SD 52.19 ± 32.299 4.69 ± 8.056 26.88 ± 30.434 16.25 ± 24.393
Male No. 8 8 8 8
Mean ± SD 77.50 ± 17.078 5.00 ± 10.0 13.75 ± 9.465 3.75 ± 4.787
Total No. 40 40 40 40
Mean ± SD 57.25 ± 31.266 4.75 ± 8.188 24.25 ± 27.828 13.75 ± 22.353
P-Value 0.178 0.824 0.554 0.385
Statistical signiﬁcance No statistical signiﬁcance
There is no statistical signiﬁcance between the sex of the patient and the BAL cellularity however the most predominant cell was neutrophils in
both male and female.
Table 5 BAL cellularity in patients using steroids.
Steroid TTT Neutrophils Lymphocytes Macrophages Epithelial cells
Yes No. 28 28 28 28
M± SD 58.93 ± 28.701 6.79 ± 9.116 17.50 ± 20.732 16.79 ± 25.915
No No. 12 12 12 12
M± SD 53.33 ± 39.328 0.0 ± 0.00 40.00 ± 37.417 6.67 ± 8.165
Total No. 40 40 40 40
M± SD 57.25 ± 31.266 4.75 ± 8.188 24.25 ± 27.828 13.75 ± 22.353
P-Value 0.771 0.041 0.153 0.548
Statistical signiﬁcance N.S Sig. N.S N.S
There was a statistical signiﬁcance between patients not on steroid and the absence of lymphocytes in BAL.
Table 3 Relation between HRCT pattern and BAL cellularity in the current study.
HRCT Pattern Neutrophils Lymphocytes Macrophages Epithelial cells
Ground Glass No. 8 8 8 8
Mean ± SD 67.50 ± 12.583 2.50 ± 5.000 21.25 ± 11.815 8.75 ± 8.539
Honey combing No. 26 26 26 26
Mean ± SD 56.92 ± 32.502 6.15 ± 9.608 30.00 ± 32.210 6.92 ± 8.301
Reticulations No. 6 6 6 6
Mean ± SD 45.00 ± 47.697 1.67 ± 2.887 3.33 ± 5.774 50.0 ± 43.589
Total No. 40 40 40 40
Mean ± SD 57.25 ± 31.26 4.75 ± 8.188 24.25 ± 27.828 13.75 ± 22.353
P-Value 0.740 0.756 0.193 0.371
Statistical signiﬁcance Not signiﬁcant
There is no statistical signiﬁcance between the HRCT pattern and the BAL cellularity however the most predominant cell was neutrophils in the
Ground glass and Honey combing HRCT pattern.
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larity however the most predominant cell was neutrophils in
both male and female (Table 4).
As regards BAL cellularity in patients using steroids, it was
found that the predominant cell was neutrophils in both pa-
tients using steroids and in those not using it (Table 5). This
may indicate that steroids did not have an effect on BAL
cellularity.The current study disagreed with Smith [8] who found that
one group of IPF patients showed an observed decrease in neu-
trophils during corticosteroid therapy. However the other
group failed to conﬁrm the ﬁrst group ﬁndings and showed
that an increase in neutrophils alone is associated with a poor
prognosis.
BAL cellularity in relation to treatment by azathioprine
showed no statistical signiﬁcance between patients on azathio-
Table 6 BAL cellularity in patients using azathioprine.
Azathioprine Neutrophils Lymphocytes Macrophages Epithelial cells
Yes No. 20 20 20 20
M± SD 52.5 ± 30.482 6.5 ± 10.554 20.50 ± 23.623 20.50 ± 29.856
No No. 20 20 20 20
M± SD 62.00 ± 32.931 3.00 ± 4.830 28.00 ± 32.335 7.00 ± 7.888
Total No. 40 40 40 40
M± SD 57.25 ± 31.266 4.75 ± 8.188 24.25 ± 27.828 13.75 ± 22.353
P-Value 0.424 0.562 0.590 0.529
Statistical signiﬁcance No statistical signiﬁcance
There is no statistical signiﬁcance between whether the patient was on azathioprine or not and the BAL cellularity, however the most
predominant cell was neutrophils in both groups.
Table 7 BAL cellularity in patients using acetylcysteine.
ACC TTT Neutrophils Lymphocytes Macrophages Epithelial cells
Yes No. 22 22 22 22
M± SD 52.27 ± 28.928 6.82 ± 10.068 20.45 ± 22.411 20.45 ± 28.324
No No. 18 18 18 18
M± SD 63.33 ± 34.641 2.22 ± 4.410 28.89 ± 34.167 5.56 ± 6.821
Total No. 40 40 40 40
M± SD 57.25 ± 31.266 4.75 ± 8.188 24.25 ± 27.828 13.75 ± 22.353
P-Value 0.320 0.263 0.643 0.268
Statistical signiﬁcance No statistical signiﬁcance
There is no statistical signiﬁcance between whether the patient was on acetylcysteine or not and the BAL cellularity, however the most
predominant cell was neutrophils in both groups.
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cell was neutrophils in both groups (Table 6). Also another
study failed to identify a signiﬁcant relationship between
BAL cellularity and either type of immunosuppressive therapy
[7].
BAL cellularity in relation to treatment by acetylcysteine
showed no statistical signiﬁcance between patients on acetyl-
cysteine or those not using it, however the most predominant
cell was neutrophils in both groups (Table 7).
As regards the correlation between the BAL cellularity and
the age, there was no statistical signiﬁcance but there was a
negative correlation between age to neutrophils and lympho-
cytes. Also there was a negative correlation between neutro-
phils and PaCO2, PaO2, SO2, FVC%, FEV1 and 6MWT
with no statistical signiﬁcance but with signiﬁcance to
FEF25–75% (Table 8).
This may indicate that BAL neutrophilia was associated
with worse oxygenation parameters and poor pulmonary func-
tion test parameters so BAL neutrophils may be associated
with poor prognosis or more severe cases.
Kinder et al. [4] found that BAL ﬂuid neutrophilia may
identify a subset of patients with disease that is more ‘‘active’’
or at a period of acceleration. They also stated that BAL ﬂuid
neutrophilia has identiﬁed patients during an accelerated phase
of tissue damage that may predispose them to an acute
exacerbation.The prognostic value of BAL ﬂuid differential cell count in
patients with idiopathic pulmonary ﬁbrosis (IPF) is unknown.
We hypothesized that baseline BAL ﬂuid cell count differential
(i.e., elevated levels of neutrophils and eosinophils, or reduced
levels of lymphocytes) would predict higher mortality among
persons with IPF [4].
There are difﬁculties in interpreting the prognostic signiﬁ-
cance of a BAL neutrophilia. It has been argued that a prom-
inent neutrophilia is indicative of a more progressive course in
IPF [11].
An increased percentage of neutrophils alone or an in-
creased percentage of neutrophils, along with either increased
eosinophils or normal to decreased lymphocytes, is associated
with clinical deterioration over the following 6–12 months [8].
In the current study, macrophages also show a positive cor-
relation with age, PaO2, 6MWT, FVC%, FEV1% with no sta-
tistical signiﬁcance but with signiﬁcance to SO2 and to FEF25–
75% and negative correlation with PaCO2 and PASP (Table 8).
This may indicate that increased macrophages in the BAL cel-
lular analysis is associated with better oxygenation parameters,
PFT parameters and 6MWT.
In contradiction to the current study, there was a study that
has shown that alveolar macrophages from patients with idio-
pathic pulmonary ﬁbrosis induce a non-type-1 T-helper-like re-
sponse and that this altered accessory cell function may
contribute to the predominance of a type-2 T-helper-like
Table 8 Correlation between BAL and different parameters.
Neutrophils Lymphocytes Macrophages Epithelial cells
Age Correlation coeﬃcient 0.196 0.188 0.135 0.388
P-Value 0.407 0.427 0.572 0.091
Statistical signiﬁcance N.S N.S N.S N.S
PCO2 Correlation coeﬃcient 0.077 0.332 0.091 0.161
P-Value 0.748 0.152 0.702 0.498
Statistical signiﬁcance N.S N.S N.S N.S
PO2 Correlation coeﬃcient 0.374 0.383 0.417 0.099
P-Value 0.104 0.095 0.068 0.679
Statistical signiﬁcance N.S N.S N.S N.S
SO2 Correlation coeﬃcient 0.410 0.376 0.458 0.097
P-Value 0.073 0.102 0.042 0.683
Statistical signiﬁcance N.S N.S Sig. N.S
6MWT Correlation coeﬃcient 0.422 0.072 0.434 0.105
P-Value 0.064 0.762 0.056 0.658
Statistical signiﬁcance N.S N.S N.S N.S
FVC% Correlation coeﬃcient 0.262 0.429 0.130 0.048
P-Value 0.264 0.059 0.584 0.840
Statistical signiﬁcance N.S N.S N.S N.S
FEV1% Correlation coeﬃcient 0.402 0.231 0.140 0.288
P-Value 0.079 0.328 0.557 0.217
Statistical signiﬁcance N.S N.S N.S N.S
FEF25–75% Correlation coeﬃcient 0.625 0.045 0.517 0.193
P-Value 0.003 0.850 0.020 0.416
Statistical signiﬁcance Sig. N.S Sig. N.S
PASP Correlation coeﬃcient 0.021 0.473 0.353 0.244
P-Value 0.929 0.035 0.127 0.300
Statistical signiﬁcance N.S Sig. N.S N.S
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tients with idiopathic pulmonary ﬁbrosis [3].
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